Citi Pharma Limited (PSX:CPHL)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
88.51
+0.45 (0.51%)
At close: Dec 15, 2025
30.24%
Market Cap20.22B
Revenue (ttm)13.30B
Net Income (ttm)894.23M
Shares Out228.46M
EPS (ttm)3.91
PE Ratio22.64
Forward PE14.05
Dividend3.50 (3.95%)
Ex-Dividend DateOct 17, 2025
Volume814,652
Average Volume2,104,306
Open88.06
Previous Close88.06
Day's Range88.06 - 89.44
52-Week Range60.50 - 109.30
Beta0.49
RSI55.63
Earnings DateFeb 26, 2026

About Citi Pharma

Citi Pharma Limited engages in the manufacture and sale of pharmaceutical, medical chemical, and botanical products in Pakistan. Its product portfolio includes capsules, tablet, syrup drops, ointment, sachet, and formulation. Citi Pharma Limited was incorporated in 2012 and is headquartered in Lahore, Pakistan. [Read more]

Industry Pharmaceuticals
Sector Healthcare
Founded 2012
Employees 531
Stock Exchange Pakistan Stock Exchange
Ticker Symbol CPHL
Full Company Profile

Financial Performance

In 2025, Citi Pharma's revenue was 13.15 billion, an increase of 6.00% compared to the previous year's 12.41 billion. Earnings were 892.04 million, an increase of 7.03%.

Financial Statements

News

There is no news available yet.